Respiratory Tract Drugs: Bronchodilators
TSEEB1 “Seebri Breezhaler”
Each capsule contains 63 micrograms of glycopyrronium bromide equivalent to 50 micrograms of glycopyrronium 50 mcg/cap; 30 cap/box
適應症：慢性阻塞性肺疾之維持治療。
Usual dose:
50 mcg (contents of one capsule) once daily
Contraindication:
Hypersensitivity to glycopyrronium bromide.
Adverse effect:
Headache, xerostomia, gastroenteritis, dyspepsia,
vomiting, Nasopharyngitis, rhinitis, urinary tract infection.
Related Entries
(Visited 15 times, 1 visits today)